#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13594	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2278	591.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1481	1481	C	790	C	734	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13594	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2278	591.4	0	HET	.	.	.	C451T	.	451	451	C	748	748	C	754	C,T	555,148	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13594	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2278	591.4	0	HET	.	.	.	C207T	.	207	207	C	504	504	C	801	C,T	611,132	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24676	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3625	676.7	0	.	n	.	0	T695C	SNP	695	695	T	1055	1055	C	773	C	718	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24676	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3625	676.7	0	.	n	.	0	A1638G	SNP	1638	1638	A	1998	1998	G	821	G,A	598,173	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24676	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3625	676.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2331	2331	C	774	C,T	708,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24676	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3625	676.7	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2957	2957	T	737	T,C	527,162	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24676	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3625	676.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2405	2405	A	751	A	712	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1644	folP	855	855	100.0	folP.l15.c30.ctg.1	1697	96.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1132	1134	AGC	176;178;179	A;G;C	159;161;160	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4638	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3305	139.3	1	SNP	p	S91F	1	.	.	271	273	TTC	510	512	TTC	213;216;212	T;T;C	193;194;190	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4638	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3305	139.3	1	SNP	p	G95N	0	.	.	283	285	GGC	522	524	GGC	217;214;215	G;G;C	189;186;187	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4638	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3305	139.3	1	SNP	p	D95G	1	.	.	283	285	GGC	522	524	GGC	217;214;215	G;G;C	189;186;187	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1344	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1378	97.0	1	SNP	p	G45D	0	.	.	133	135	GGC	472	474	GGC	156;157;162	G;G;C	142;144;147	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	678	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1062	63.4	0	.	n	.	0	A197.	DEL	197	197	A	611	611	A	160	A	149	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5282	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2861	182.7	1	SNP	p	D86N	0	.	.	256	258	GAC	544	546	GAC	205;203;204	G;A;C	187;184;187	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5282	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2861	182.7	1	SNP	p	R87W	0	.	.	259	261	CGT	547	549	CGT	204;206;204	C;G;T	188;190;187	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5282	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2861	182.7	1	SNP	p	S87R	1	.	.	259	261	CGT	547	549	CGT	204;206;204	C;G;T	188;190;187	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5282	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2861	182.7	1	SNP	p	R87I	0	.	.	259	261	CGT	547	549	CGT	204;206;204	C;G;T	188;190;187	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5282	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2861	182.7	1	SNP	p	S88P	0	.	.	262	264	TCC	550	552	TCC	205;205;204	T;C;C	188;188;189	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3674	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2650	137.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1529	1531	GGC	172;170;168	G;G;C	160;157;154	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3538	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2431	143.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1186	1188	GCC	184;185;184	G,A;C;C	168,1;171;168	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3538	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2431	143.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1189	1191	ATG	183;185;184	A;T;G	169;170;170	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3538	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2431	143.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1201	1203	ACC	176;177;176	A;C;C	163;167;167	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3538	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2431	143.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1201	1203	ACC	176;177;176	A;C;C	163;167;167	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3538	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2431	143.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1702	1704	ACC	186;185;186	A;C;C	174;176;177	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3538	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2431	143.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1756	1758	GCG	164;166;169	G;C;G	150;148;153	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3538	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2431	143.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1756	1758	GCG	164;166;169	G;C;G	150;148;153	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3538	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2431	143.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1879	1881	GGT	167;166;164	G;G;T	152;150;146	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3538	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2431	143.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1888	1890	AGC	156;156;155	A;G;C,T	140;139;136,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3538	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2431	143.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1906	1908	CCG	136;135;134	C,G;C,G;G	105,3;105,1;104	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5340	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3155	168.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1617	1619	CCG	199;201;200	C;C;G	168;178;172	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2344	porA	1146	1146	99.91	porA.l15.c17.ctg.1	1736	133.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	573	573	C	161	C	144	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2644	porB1b	1038	1038	99.61	porB1b.l15.c17.ctg.1	1495	174.1	0	.	p	.	0	I45V	NONSYN	133	135	ATT	466	468	GTT	237;241;238	G;T;T	214;217;219	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2644	porB1b	1038	1038	99.61	porB1b.l15.c17.ctg.1	1495	174.1	0	.	p	.	0	G210R	NONSYN	628	630	GGA	961	963	AGA	237;237;235	A;G;A	226;225;225	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2644	porB1b	1038	1038	99.61	porB1b.l15.c17.ctg.1	1495	174.1	0	.	p	.	0	S217N	NONSYN	649	651	AGT	982	984	AAT	240;237;236	A;A,T;T	228;225,1;225	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2644	porB1b	1038	1038	99.61	porB1b.l15.c17.ctg.1	1495	174.1	0	.	p	.	0	G256D	NONSYN	766	768	GGT	1099	1101	GAT	210;211;207	G;A;T	183;186;182	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2644	porB1b	1038	1038	99.61	porB1b.l15.c17.ctg.1	1495	174.1	1	SNP	p	G120K	1	.	.	358	360	AAG	691	693	AAG	218;218;217	A;A;G	199;201;197	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2644	porB1b	1038	1038	99.61	porB1b.l15.c17.ctg.1	1495	174.1	1	SNP	p	N121D	0	.	.	361	363	AAC	694	696	AAC	218;219;220	A;A;C	201;201;201	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2644	porB1b	1038	1038	99.61	porB1b.l15.c17.ctg.1	1495	174.1	1	SNP	p	A121N	1	.	.	361	363	AAC	694	696	AAC	218;219;220	A;A;C	201;201;201	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9738	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4786	202.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1126	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1047	106.2	1	SNP	p	V57M	1	.	.	169	171	ATG	620	622	ATG	235;236;235	A,G;T;G	219,1;220;218	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
